Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01362634 · ClinicalTrials.gov registry record · NA
A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
A NA study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 750
- Enrollment target
NCT01362634: Completed NA study, sponsored by Nova Southeastern University.
NCT01362634 is a NA study that has completed, run by Nova Southeastern University. The registered enrollment target is 750 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01362634, a NA study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
Study Summary
The proposed study is a three-armed randomized clinical trial. A total of 750 clients will be randomly assigned (using a random number table) to the interviewer-administered intervention, the self-administered intervention, and waitlist control conditions upon completion of screening, informed consent, HIV pretest counseling and test administration, and collection of baseline risk behavior data. Outcomes will be measured at 3, 6 and 12 months.
Interventions
- BEHAVIORAL Trans-theoretical Process of Change Model-self
- BEHAVIORAL Trans-theoretical Process of Change Model - interviewer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-07-31 |
| Phase | NA |
What the finished NCT01362634 record still lists
NCT01362634 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Trans-theoretical Process of Change Model-self is the first listed.
NCT01362634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01362634 about?
NCT01362634 is a clinical study titled "A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV". The proposed study is a three-armed randomized clinical trial. A total of 750 clients will be randomly assigned (using a random number table) to the interviewer-administered intervention, the self-administered intervention, and waitlist control conditions upon completion of screening, informed conse...
What is the current status of trial NCT01362634?
This trial is currently completed. It is a NA study. The enrollment target is 750 participants. The study started on 2011-08. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT01362634?
The interventions under investigation include: Trans-theoretical Process of Change Model-self (BEHAVIORAL), Trans-theoretical Process of Change Model - interviewer (BEHAVIORAL).
Who is sponsoring clinical trial NCT01362634?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01362634's enrollment target sits among peer trials
750 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia